Page last updated: 2024-09-04

n-succinyl-4-amino-2,2,6,6-tetramethylpiperidine-1-oxyl and Brain Injuries

n-succinyl-4-amino-2,2,6,6-tetramethylpiperidine-1-oxyl has been researched along with Brain Injuries in 1 studies

*Brain Injuries: Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brant-Zawadzki, M; Brasch, RC; Cann, CE; Enzmann, DR; Fike, JR; Nitecki, DE; Sheldon, P; Tozer, TN; Tuck, LD; Wesbey, GE1

Other Studies

1 other study(ies) available for n-succinyl-4-amino-2,2,6,6-tetramethylpiperidine-1-oxyl and Brain Injuries

ArticleYear
Brain nuclear magnetic resonance imaging enhanced by a paramagnetic nitroxide contrast agent: preliminary report.
    AJR. American journal of roentgenology, 1983, Volume: 141, Issue:5

    Topics: Animals; Brain; Brain Injuries; Contrast Media; Cyclic N-Oxides; Dogs; Drug Evaluation, Preclinical; Encephalitis; Magnetic Resonance Spectroscopy; Radiation Injuries, Experimental

1983